
Drug Discovery Informatics Market by Solutions (Services, Software), Functions (Docking, Libraries & Database Preparation, Molecular Modeling), End-User, Application - Global Forecast 2024-2030
Description
Drug Discovery Informatics Market by Solutions (Services, Software), Functions (Docking, Libraries & Database Preparation, Molecular Modeling), End-User, Application - Global Forecast 2024-2030
The Drug Discovery Informatics Market size was estimated at USD 2.90 billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 9.92% to reach USD 5.64 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Drug Discovery Informatics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Discovery Informatics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Drug Discovery Informatics Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Agilent Technologies, Inc., Aragen Life Sciences Ltd., Boehringer Ingelheim International GmbH, Cadence Design Systems, Inc., Certara, Inc., Charles River Laboratories International, Inc., ChemAxon Ltd., Cognizant Technology Solutions Corporation, Collaborative Drug Discovery, Inc, Crown Bioscience, Inc., Dassault Systèmes SE, Eurofins DiscoverX Products LLC, Evotec AG, Illumina, Inc., Infosys Limited, InSilico Medicine, International Business Machines Corporation, Jubilant Biosys Ltd., Oracle Corporation, PerkinElmer Inc., Schrödinger, Inc., Selvita S.A., Thermo Fisher Scientific Inc., and WuXi AppTec Co., Ltd..
Market Segmentation & Coverage
This research report categorizes the Drug Discovery Informatics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Solutions
Services
Software
Functions
Docking
Libraries & Database Preparation
Molecular Modeling
Sequencing & Target Data Analysis
End-User
Contract Research Organizations (CRO)
Pharmaceutical & Biotechnology Companies
Application
Drug Development
Clinical Trials
Preclinical Testing
Drug Discovery
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Drug Discovery Informatics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Discovery Informatics Market?
3. What are the technology trends and regulatory frameworks in the Drug Discovery Informatics Market?
4. What is the market share of the leading vendors in the Drug Discovery Informatics Market?
5. Which modes and strategic moves are suitable for entering the Drug Discovery Informatics Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
189 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Drug Discovery Informatics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing need for precision medicine in rare and orphan disease management
- 5.1.1.2. Favorable government support for drug discovery procedures
- 5.1.1.3. Rising use of bioinformatic software for drug discovery and development
- 5.1.2. Restraints
- 5.1.2.1. Involvement of huge cost for development of bio-informatic infrastructure
- 5.1.3. Opportunities
- 5.1.3.1. Potential research investments for the development of drug discovery informatics
- 5.1.3.2. Integration of next-generation technologies in drug discovery procedures
- 5.1.4. Challenges
- 5.1.4.1. Lack of skilled and experienced professionals
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Drug Discovery Informatics Market, by Solutions
- 6.1. Introduction
- 6.2. Services
- 6.3. Software
- 7. Drug Discovery Informatics Market, by Functions
- 7.1. Introduction
- 7.2. Docking
- 7.3. Libraries & Database Preparation
- 7.4. Molecular Modeling
- 7.5. Sequencing & Target Data Analysis
- 8. Drug Discovery Informatics Market, by End-User
- 8.1. Introduction
- 8.2. Contract Research Organizations (CRO)
- 8.3. Pharmaceutical & Biotechnology Companies
- 9. Drug Discovery Informatics Market, by Application
- 9.1. Introduction
- 9.2. Drug Development
- 9.3.1. Clinical Trials
- 9.3.2. Preclinical Testing
- 9.3. Drug Discovery
- 10. Americas Drug Discovery Informatics Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Drug Discovery Informatics Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Drug Discovery Informatics Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Accenture PLC
- 14.1.2. Agilent Technologies, Inc.
- 14.1.3. Aragen Life Sciences Ltd.
- 14.1.4. Boehringer Ingelheim International GmbH
- 14.1.5. Cadence Design Systems, Inc.
- 14.1.6. Certara, Inc.
- 14.1.7. Charles River Laboratories International, Inc.
- 14.1.8. ChemAxon Ltd.
- 14.1.9. Cognizant Technology Solutions Corporation
- 14.1.10. Collaborative Drug Discovery, Inc
- 14.1.11. Crown Bioscience, Inc.
- 14.1.12. Dassault Systèmes SE
- 14.1.13. Eurofins DiscoverX Products LLC
- 14.1.14. Evotec AG
- 14.1.15. Illumina, Inc.
- 14.1.16. Infosys Limited
- 14.1.17. InSilico Medicine
- 14.1.18. International Business Machines Corporation
- 14.1.19. Jubilant Biosys Ltd.
- 14.1.20. Oracle Corporation
- 14.1.21. PerkinElmer Inc.
- 14.1.22. Schrödinger, Inc.
- 14.1.23. Selvita S.A.
- 14.1.24. Thermo Fisher Scientific Inc.
- 14.1.25. WuXi AppTec Co., Ltd.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. DRUG DISCOVERY INFORMATICS MARKET RESEARCH PROCESS
- FIGURE 2. DRUG DISCOVERY INFORMATICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. DRUG DISCOVERY INFORMATICS MARKET DYNAMICS
- FIGURE 7. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2030 (%)
- FIGURE 8. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2030 (%)
- FIGURE 10. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.